JANUS HENDERSON GROUP PLC - 31 Jan 2025 SCHEDULE 13G Report for BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
BRIGHT MINDS BIOSCIENCES INC. Common Stock
Symbol
DRUG
Shares outstanding
6,939,448 shares
Disclosed Ownership
804,976 shares
Ownership
11.6%
Form type
SCHEDULE 13G
Filing time
07 Feb 2025, 10:49:46 UTC
Date of event
31 Jan 2025
Next filing
07 Apr 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 11.6% 804,976 0 804,976 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 10.4% 719,574 0 719,574 Kristin Mariani Head of North America Compliance, CCO